Pricing Log in Create free account
Friday 6 November 2026 Export SPOK’s income statement to Excel — free account

Spok Holdings, Inc.

SPOK Healthcare Health Information Services

Spok Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $139.7 million, up 1.49% from fiscal 2024.

Revenue
−2.56%
EPS
+190.3%
Free cash flow
+61.6%

Quarter to September 2026, against a year earlier

11.77 0.02 +0.17%
Market cap
$245.9M
P/E
12.9×
Fwd P/E
16.2×
Dividend yield
10.8%
F-score
6/9
Altman Z
4.04
Beneish M
−2.76
Dividend safety
32/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Bought, $m 0.47
Sold, $m 0.63
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — 1 1 — — — — —
Sell — — — — — 1 — — 2 — — 1
Insider Ownership 2.19%

Capital & Financial Ratios $m

Size
Market Cap 245.93
Revenue ttm 135.10
Net income ttm 18.75
Free cash flow ttm 30.07
Net debt Q (30.07)
Valuation
P/E 12.86
Forward P/E 16.20
Price / sales 1.80
Forward P/S Powerpack
Price / FCF 8.09
Price / book 1.68
Financial health
Current ratio Q 1.29
Debt / equity Q 0.00 (at or below 0.5: strong)
Interest coverage Q 120.78
Growth
Revenue growth Q −2.56% (below 0%: shrinking)
Operating income growth Q +29.32% (above 0%: growing)
EPS, this year −12.00% (below 0%: weak)
EPS, next year A +3.75%
Revenue, next year A −0.29% (below 0%: weak)
EPS, past 5 yrs —
EPS, next 5 yrs A —

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.6×, against a ten-year median of 1.3×; over the ten years it ranged from 0.6× in 2022 to 2.5× in 2025.
P/E against its own 10 years 35.69%
10-year low 10-year high
P/S against its own 10 years 54.79%
10-year low 10-year high
P/B against its own 10 years 76.05%
10-year low 10-year high
EV/Sales against its own 10 years 71.69%
10-year low 10-year high
EV/FCF against its own 10 years 4.98%
10-year low 10-year high

Dividends

Yield
10.8%
Annual rate
1.25
Payout ratio
140.8%
Growth, 2018–26
+12.1%/yr
  1. 0.50 ’18
  2. 0.50 ’19 +0
  3. 0.50 ’20 +0
  4. 0.50 ’21 +0
  5. 1.25 ’22 +150
  6. 1.25 ’23 +0
  7. 1.25 ’24 +0
  8. 1.25 ’25 +0
  9. 1.25 ’26 +0
paid change on the year, %

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 32 29 25 30
Receivables 23 22 23 18
Inventory — — — —
Other 1 1 1 1
64 61 58 57
2023 2024 2025 Q'26
Payables 6 6 4 2
ST’ Debt — — — —
Other 4 5 5 4
48 49 49 44

Compound Annual Growth %

10y 5y 3y
Sales (3.01%) (1.17%) 1.27%
Cash Flow (3.62%) 2.04% 64.90%
Earnings (14.96%) 0.00% (10.10%)
Book Value (7.80%) (6.11%) (5.07%)

Earnings Trends EPS, adjusted, against the consensus

Q2 FY26 Estimate 0.15 Actual 0.20

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q3 FY25 0.19 0.15 Miss by 0.04
Q4 FY25 0.18 0.14 Miss by 0.04
Q1 FY26 0.18 0.09 Miss by 0.09
Q2 FY26 0.15 0.20 Beat by 0.05

EPS $

Mar Jun Sep Dec Year
’26 0.09 0.20 0.46 — —
’25 0.25 0.22 0.15 0.14 0.75
’24 0.21 0.17 0.18 0.18 0.73
’23 0.15 0.23 0.22 0.17 0.77
’22 (0.37) 0.10 0.15 1.21 1.09
’21 (0.12) (0.04) (0.13) (0.86) (1.14)
’20 (0.24) 0.20 0.16 (2.44) (2.32)
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 33 35 33 — —
’25 36 36 34 34 140
’24 35 34 35 34 138
’23 33 36 35 34 139
’22 34 34 34 33 135
’21 36 36 36 35 142
’20 37 36 38 37 148
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 2 6 13 — —
’25 2 7 8 12 29
’24 2 7 11 8 29
’23 3 9 3 12 26
’22 (5) (1) 6 7 6
’21 1 3 6 (2) 8
’20 1 5 14 5 26
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 2 6 12 — —
’25 2 6 8 10 25
’24 1 7 10 8 26
’23 2 7 3 11 23
’22 (6) (2) 5 5 3
’21 (3) (1) 2 (5) (7)
’20 (1) 1 11 2 11
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

3
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 180 171 169 160 148 142 135 139 138 140 135 (2.7%) 139 — — (0.3%)
Gross margin, % 82.93 83.40 80.88 79.67 79.12 77.16 78.99 80.51 79.15 78.68 78.58 (4.2) pt
EBT 23 12 (2) (13) (22) (27) 1 22 20 21 26 (0.8%)
EBT margin, % 12.79 6.75 (1.29) (8.37) (14.69) (19.23) 0.74 16.06 14.55 15.35 19.12 +2.6 pt
Net income 14 (15) (1) (11) (44) (22) 22 16 15 16 19 +1.4%
Per share, $
Per share, $ Revenue 8.72 8.47 8.62 8.40 7.79 7.33 6.84 6.97 6.80 6.80 6.46 (2.7%)
Earnings 0.68 (0.76) (0.08) (0.56) (2.32) (1.14) 1.11 0.79 0.74 0.77 0.90 +1.4%
Cash flow 1.82 0.77 0.52 0.61 1.37 0.41 0.33 1.31 1.43 1.41 1.60 (2.8%)
Capex (0.30) (0.46) (0.30) (0.25) (0.77) (0.79) (0.19) (0.17) (0.16) (0.18) (0.16) (5.5%)
Free cash flow 1.52 0.31 0.22 0.36 0.60 (0.37) 0.14 1.14 1.27 1.23 1.44 (2.4%)
Book value 15.65 14.38 13.96 13.10 10.54 8.95 8.70 8.21 7.65 7.12 6.91 (8.4%)
Shares, m 21 20 20 19 19 19 20 20 20 21 21 0.0%
Valuation, ×
Valuation, × P/E 31.30 0.00 0.00 0.00 0.00 0.00 7.65 19.52 21.69 17.13 12.86 9.7
P/S 2.48 1.81 1.54 1.46 1.43 1.27 1.24 2.21 2.36 1.94 1.80 1.8
P/B 1.38 1.07 0.95 0.93 1.06 1.04 0.98 1.88 2.10 1.85 1.68 1.3
EV/Sales 1.78 1.19 1.02 0.97 0.90 0.85 0.98 1.98 2.15 1.76 1.58 1.4
EV/FCF 10.19 32.23 39.43 22.78 11.62 (16.71) 48.98 12.11 11.50 9.76 7.09 18.2
Cash, $m
Cash, $m Operating cash flow 38 16 10 12 26 8 6 26 29 29 33 (2.8%)
Capex (6) (9) (6) (5) (15) (15) (4) (3) (3) (4) (3) (5.5%)
Free cash flow 31 6 4 7 11 (7) 3 23 26 25 30 (2.4%)
Balance, $m
Balance, $m Working capital 100 96 86 66 61 39 16 16 13 9 13 (23.7%)
Net debt (126) (107) (87) (77) (79) (60) (36) (32) (29) (25) (30) (16.3%)
Shareholders’ equity 322 291 275 250 201 174 171 164 155 146 145 (8.4%)
Returns, %
Returns, % ROA 3.61 (4.16) (0.44) (3.32) (14.81) (8.44) 8.87 6.64 6.73 7.50 9.19 +3.9 pt
ROIC 7.05 3.65 (1.06) (5.72) (11.62) (15.18) 0.11 10.07 9.44 10.17 9.53 +3.1 pt
ROE 4.29 (5.00) (0.52) (4.10) (19.62) (11.85) 12.68 9.36 9.40 10.55 12.79 +6.3 pt
People
People Employees 587 596 596 638 602 563 376 384 410 421 — (3.6%)
Revenue/emp, $m 0.31 0.29 0.28 0.25 0.25 0.25 0.36 0.36 0.34 0.33 — +0.9%
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 2 Nov 2026

Spok Holdings, Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
CARL Carlsmed, Inc. $418.3M — (loss-making) — (loss-making) +56.75% (above 0%: growing) n/m −6.84% (below 0%: shrinking) 76.78% (58.27%) Compare
CTEV Claritev Corporation $342.7M — (loss-making) — (loss-making) +6.59% (above 0%: growing) n/m +49.10% (above 0%: growing) 73.72% 9.09% Compare
SPOK Spok Holdings, Inc. $245.9M 12.9× 16.2× −2.56% (below 0%: shrinking) +190.31% (above 0%: growing) +61.57% (above 0%: growing) 79.66% 17.08%
AMWL American Well Corporation $208.5M — (loss-making) — (loss-making) −12.96% (below 0%: shrinking) n/m +21.98% (above 0%: growing) 52.99% (23.79%) Compare
SY So-Young International Inc. Sponsored ADR $177.7M — (loss-making) 12.8× +40.84% (above 0%: growing) n/m −798.37% (below 0%: shrinking) 44.11% (8.64%) Compare
DH Definitive Healthcare Corp. $163.7M — (loss-making) — (loss-making) −8.99% (below 0%: shrinking) n/m −32.60% (below 0%: shrinking) 77.27% (9.09%) Compare
OPRX OptimizeRx Corp. $163.3M 35.8× 41.7× −29.77% (below 0%: shrinking) n/m +89.86% (above 0%: growing) 76.51% (0.43%) Compare
HCAT Health Catalyst, Inc. $112.9M — (loss-making) — (loss-making) −26.26% (below 0%: shrinking) n/m +65.58% (above 0%: growing) 42.71% 89.08% Compare
LFMD LifeMD, Inc. $110.4M — (loss-making) — (loss-making) −3.55% (below 0%: shrinking) n/m −247.52% (below 0%: shrinking) 88.82% (15.08%) Compare
Median of peers $170.7M — — −6.27% — +7.57% 75.12% (8.86%)

All 44 Health Information Services stocks →

Pay and ownership Proxy statement filed 30 April 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 2.41m 2.02m 190.00
2024 2.24m 2.65m 213.00
2023 2.37m 4.21m 190.00
2022 2.24m 1.99m 91.00
2021 2.12m 1.72m 88.00

Ownership

Directors and executive officers, together 7.28%
BlackRock, Inc. 6.75%
Braeside Investments, LLC 5.10%
Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation 5.06%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

Spok Holdings, Inc. (SPOK) Latest News

30 Oct

Impact 3 · · Simply Wall St. earnings

28 Oct

Impact 4 · · MarketBeat transcript
Impact 4 · · Business Wire
Impact 3 · · Associated Press

21 Oct

Impact 3 · · Business Wire

19 Oct

Impact 4 · · Business Wire

22 Sep

Impact 3 · · Business Wire

7 Aug

Impact 3 · · The Motley Fool transcript

30 Jul

Impact 4 ·
Impact 3 · · Moby transcript

29 Jul

Impact 3 · · MarketBeat
Impact 3 ·
Impact 3 ·

24 Jun

Impact 3 · · Business Wire

29 Apr

Impact 4 · · MarketBeat
Impact 4 · · Zacks
Impact 4 · · Business Wire

21 Apr

Impact 4 · · The Motley Fool transcript

14 Apr

Impact 4 · · Business Wire

26 Feb

Impact 4 · · MarketBeat
Impact 4 ·

25 Feb

Impact 4 · · Associated Press Finance
Impact 3 · · Business Wire

10 Feb

Impact 3 · · Simply Wall St.

4 Feb

Impact 3 · · Business Wire

1 Feb

Impact 3 · · Simply Wall St.

15 Jan

Impact 3 · · Simply Wall St.

26 Dec

Impact 4 · · Simply Wall St.

23 Dec

Impact 3 · · Zacks

18 Dec

Impact 3 ·
stockrow.com/SPOK · Data as of Nov 2, 2026 · For information only; not investment advice. · © 2026 stockrow.com